Download Yi Shi - Duke University`s Fuqua School of Business

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript 
The East Asia Regional Advisory Board
The Fuqua School of Business
Yi SHI, PhD., B’99 Managing Partner Lily Asia Ventures Shanghai, China Yi Shi is the Managing Partner of Lilly Asia Ventures, a venture capital fund affiliated with Eli Lilly and investing in the healthcare sector in Asia, particularly China. Yi has been in the current role since the fund’s founding in 2008; prior to this he worked at Eli Lilly and Company with a diverse set of experiences including operations, marketing, business development licensing, and corporate strategy. Currently, he serves on the Board of HD Biosciences, Chipscreen Biosciences, Beta Pharma, BrightGene Biomedical, Novast Holdings, Sinqi Pharmaceuticals, CPC Scientific, and Innovent Biologics. Yi’s education includes a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Sciences in Biology from the University of Science and Technology of China. The Fuqua School of Business Duke University 100 Fuqua Drive Box 90120 Durham, NC 27708‐0120 USA www.fuqua.duke.edu The East Asia Office (Shanghai)
The Fuqua School of Business Suite 730, Shanghai Centre 1376 West Nanjing Road Shanghai, China Tel: +86 21 62898365
Related documents